BioLife Solutions, Inc. completed its 2023 annual meeting of stockholders, where directors were re-elected, executive officer compensation was approved, the appointment of Grant Thornton LLP as the independent registered public accounting firm was ratified, and the 2023 Omnibus Performance Incentive Plan was approved.